APO Research
Talk to an analyst

APO RESEARCH · REPORT

Molecular Pathology Services

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Molecular Pathology Services Market Outlook and Growth Opportunities 2026

1 May 2026194 pages

Choose your research edition.

Industry ResearchMolecular Pathology Services Industry Research Report 2026115 pages · $2,950 USDIndustry Growth & TrendsGlobal Molecular Pathology Services Industry Growth and Trends Forecast to 2032104 pages · $3,450 USDMarket StructureGlobal Molecular Pathology Services Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032194 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Molecular Pathology Services Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal Molecular Pathology Services Market Analysis and Forecast 2026-2032243 pages · $4,950 USD

Market perspective

The global Molecular Pathology Services market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Molecular Pathology Services is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Molecular Pathology Services is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Molecular Pathology Services is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Molecular Pathology Services market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Molecular Pathology Services market include Quest Diagnostics, Labcorp, Sonic Healthcare, NeoGenomics, Foundation Medicine, Caris Life Sciences, Tempus, Guardant Health and Exact Sciences, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Molecular Pathology Services market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Molecular Pathology Services and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Molecular Pathology Services revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Molecular Pathology Services market.

Molecular Pathology Services Segment by Company

Quest Diagnostics

Labcorp

Sonic Healthcare

NeoGenomics

Foundation Medicine

Caris Life Sciences

Tempus

Guardant Health

Exact Sciences

Eurofins

Unilabs

Molecular Pathology Services Segment by Type

Solid Tumor Molecular Pathology Services

Hematologic Malignancy Molecular Pathology Services

Hereditary Disease Molecular Pathology Services

Infectious Disease Molecular Testing Services

Rare Disease Molecular Pathology Services

Others

Molecular Pathology Services Segment by Application

Hospitals and Medical Centers

Independent Clinical Laboratories

Academic and Research Institutes

Biopharmaceutical Companies

Others

Molecular Pathology Services Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Molecular Pathology Services status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Molecular Pathology Services key companies, revenue, market share, and recent developments.

3. To split the Molecular Pathology Services breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Molecular Pathology Services market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Molecular Pathology Services significant trends, drivers, influence factors in global and regions.

6. To analyze Molecular Pathology Services competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Molecular Pathology Services market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Molecular Pathology Services and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Molecular Pathology Services.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Molecular Pathology Services industry.

Chapter 3: Detailed analysis of Molecular Pathology Services company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Molecular Pathology Services in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Molecular Pathology Services in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Molecular Pathology Services Industry Trends Table 2. Molecular Pathology Services Industry Drivers Table 3. Molecular Pathology Services Industry Opportunities and Challenges Table 4. Molecular Pathology Services Industry Restraints Table 5. Global Molecular Pathology Services Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Molecular Pathology Services Revenue Share by Company (2021-2026) Table 7. Global Molecular Pathology Services Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Molecular Pathology Services Key Company Manufacturing Base & Headquarters Table 9. Global Molecular Pathology Services Company, Product Type & Application Table 10. Global Molecular Pathology Services Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Molecular Pathology Services by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Solid Tumor Molecular Pathology Services Table 15. Significant Companies of Hematologic Malignancy Molecular Pathology Services Table 16. Significant Companies of Hereditary Disease Molecular Pathology Services Table 17. Significant Companies of Infectious Disease Molecular Testing Services Table 18. Significant Companies of Rare Disease Molecular Pathology Services Table 19. Significant Companies of Others Table 20. Global Molecular Pathology Services Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 21. Global Molecular Pathology Services Sales Value by Type (2021-2026) & (US$ Million) Table 22. Global Molecular Pathology Services Sales Value by Type (2027-2032) & (US$ Million) Table 23. Global Molecular Pathology Services Sales Value Share by Type (2021-2026) Table 24. Global Molecular Pathology Services Sales Value Share by Type (2027-2032) Table 25. Significant Companies of Hospitals and Medical Centers Table 26. Significant Companies of Independent Clinical Laboratories Table 27. Significant Companies of Academic and Research Institutes Table 28. Significant Companies of Biopharmaceutical Companies Table 29. Significant Companies of Others Table 30. Global Molecular Pathology Services Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global Molecular Pathology Services Sales Value by Application (2021-2026) & (US$ Million) Table 32. Global Molecular Pathology Services Sales Value by Application (2027-2032) & (US$ Million) Table 33. Global Molecular Pathology Services Sales Value Share by Application (2021-2026) Table 34. Global Molecular Pathology Services Sales Value Share by Application (2027-2032) Table 35. Global Molecular Pathology Services Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 36. Global Molecular Pathology Services Sales Value by Region (2021-2026) & (US$ Million) Table 37. Global Molecular Pathology Services Sales Value Share by Region (2021-2026) Table 38. Global Molecular Pathology Services Sales Value by Region (2027-2032) & (US$ Million) Table 39. Global Molecular Pathology Services Sales Value Share by Region (2027-2032) Table 40. Global Molecular Pathology Services Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 41. Global Molecular Pathology Services Sales Value by Country (2021-2026) & (US$ Million) Table 42. Global Molecular Pathology Services Sales Value Market Share by Country (2021-2026) Table 43. Global Molecular Pathology Services Sales Value by Country (2027-2032) & (US$ Million) Table 44. Global Molecular Pathology Services Sales Value Market Share by Country (2027-2032) Table 45. Quest Diagnostics Company Information Table 46. Quest Diagnostics Business Overview Table 47. Quest Diagnostics Molecular Pathology Services Revenue (US$ Million) and Gross Margin (2021-2026) Table 48. Quest Diagnostics Molecular Pathology Services Product Portfolio Table 49. Quest Diagnostics Recent Development Table 50. Labcorp Company Information Table 51. Labcorp Business Overview Table 52. Labcorp Molecular Pathology Services Revenue (US$ Million) and Gross Margin (2021-2026) Table 53. Labcorp Molecular Pathology Services Product Portfolio Table 54. Labcorp Recent Development Table 55. Sonic Healthcare Company Information Table 56. Sonic Healthcare Business Overview Table 57. Sonic Healthcare Molecular Pathology Services Revenue (US$ Million) and Gross Margin (2021-2026) Table 58. Sonic Healthcare Molecular Pathology Services Product Portfolio Table 59. Sonic Healthcare Recent Development Table 60. NeoGenomics Company Information Table 61. NeoGenomics Business Overview Table 62. NeoGenomics Molecular Pathology Services Revenue (US$ Million) and Gross Margin (2021-2026) Table 63. NeoGenomics Molecular Pathology Services Product Portfolio Table 64. NeoGenomics Recent Development Table 65. Foundation Medicine Company Information Table 66. Foundation Medicine Business Overview Table 67. Foundation Medicine Molecular Pathology Services Revenue (US$ Million) and Gross Margin (2021-2026) Table 68. Foundation Medicine Molecular Pathology Services Product Portfolio Table 69. Foundation Medicine Recent Development Table 70. Caris Life Sciences Company Information Table 71. Caris Life Sciences Business Overview Table 72. Caris Life Sciences Molecular Pathology Services Revenue (US$ Million) and Gross Margin (2021-2026) Table 73. Caris Life Sciences Molecular Pathology Services Product Portfolio Table 74. Caris Life Sciences Recent Development Table 75. Tempus Company Information Table 76. Tempus Business Overview Table 77. Tempus Molecular Pathology Services Revenue (US$ Million) and Gross Margin (2021-2026) Table 78. Tempus Molecular Pathology Services Product Portfolio Table 79. Tempus Recent Development Table 80. Guardant Health Company Information Table 81. Guardant Health Business Overview Table 82. Guardant Health Molecular Pathology Services Revenue (US$ Million) and Gross Margin (2021-2026) Table 83. Guardant Health Molecular Pathology Services Product Portfolio Table 84. Guardant Health Recent Development Table 85. Exact Sciences Company Information Table 86. Exact Sciences Business Overview Table 87. Exact Sciences Molecular Pathology Services Revenue (US$ Million) and Gross Margin (2021-2026) Table 88. Exact Sciences Molecular Pathology Services Product Portfolio Table 89. Exact Sciences Recent Development Table 90. Eurofins Company Information Table 91. Eurofins Business Overview Table 92. Eurofins Molecular Pathology Services Revenue (US$ Million) and Gross Margin (2021-2026) Table 93. Eurofins Molecular Pathology Services Product Portfolio Table 94. Eurofins Recent Development Table 95. Unilabs Company Information Table 96. Unilabs Business Overview Table 97. Unilabs Molecular Pathology Services Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 98. Unilabs Molecular Pathology Services Product Portfolio Table 99. Unilabs Recent Development Table 100. Research Programs/Design for This Report Table 101. Authors List of This Report Table 102. Secondary Sources Table 103. Primary Sources List of Figures Figure 1. Molecular Pathology Services Product Image Figure 2. Global Molecular Pathology Services Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Molecular Pathology Services Market Size (2021-2032) & (US$ Million) Figure 4. Global Molecular Pathology Services Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Solid Tumor Molecular Pathology Services Image Figure 8. Hematologic Malignancy Molecular Pathology Services Image Figure 9. Hereditary Disease Molecular Pathology Services Image Figure 10. Infectious Disease Molecular Testing Services Image Figure 11. Rare Disease Molecular Pathology Services Image Figure 12. Others Image Figure 13. Global Molecular Pathology Services Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 14. Global Molecular Pathology Services Sales Value Share 2021 VS 2025 VS 2032 Figure 15. Global Molecular Pathology Services Sales Value Share by Type (2021-2032) Figure 16. Hospitals and Medical Centers Image Figure 17. Independent Clinical Laboratories Image Figure 18. Academic and Research Institutes Image Figure 19. Biopharmaceutical Companies Image Figure 20. Others Image Figure 21. Global Molecular Pathology Services Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 22. Global Molecular Pathology Services Sales Value Share 2021 VS 2025 VS 2032 Figure 23. Global Molecular Pathology Services Sales Value Share by Application (2021-2032) Figure 24. Global Molecular Pathology Services Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 25. Global Molecular Pathology Services Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 26. North America Molecular Pathology Services Sales Value (2021-2032) & (US$ Million) Figure 27. North America Molecular Pathology Services Sales Value Share by Country (%), 2025 VS 2032 Figure 28. Europe Molecular Pathology Services Sales Value (2021-2032) & (US$ Million) Figure 29. Europe Molecular Pathology Services Sales Value Share by Country (%), 2025 VS 2032 Figure 30. Asia-Pacific Molecular Pathology Services Sales Value (2021-2032) & (US$ Million) Figure 31. Asia-Pacific Molecular Pathology Services Sales Value Share by Country (%), 2025 VS 2032 Figure 32. South America Molecular Pathology Services Sales Value (2021-2032) & (US$ Million) Figure 33. South America Molecular Pathology Services Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Middle East & Africa Molecular Pathology Services Sales Value (2021-2032) & (US$ Million) Figure 35. Middle East & Africa Molecular Pathology Services Sales Value Share by Country (%), 2025 VS 2032 Figure 36. USA Molecular Pathology Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 37. USA Molecular Pathology Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 38. USA Molecular Pathology Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 39. Canada Molecular Pathology Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 40. Canada Molecular Pathology Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 41. Canada Molecular Pathology Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 42. Mexico Molecular Pathology Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. Mexico Molecular Pathology Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. Mexico Molecular Pathology Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. Germany Molecular Pathology Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. Germany Molecular Pathology Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. Germany Molecular Pathology Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. France Molecular Pathology Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. France Molecular Pathology Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. France Molecular Pathology Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. U.K. Molecular Pathology Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. U.K. Molecular Pathology Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. U.K. Molecular Pathology Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. Italy Molecular Pathology Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. Italy Molecular Pathology Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. Italy Molecular Pathology Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. Spain Molecular Pathology Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. Spain Molecular Pathology Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. Spain Molecular Pathology Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Russia Molecular Pathology Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Russia Molecular Pathology Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Russia Molecular Pathology Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. Netherlands Molecular Pathology Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. Netherlands Molecular Pathology Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. Netherlands Molecular Pathology Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Nordic Countries Molecular Pathology Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Nordic Countries Molecular Pathology Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Nordic Countries Molecular Pathology Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. China Molecular Pathology Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. China Molecular Pathology Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. China Molecular Pathology Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. Japan Molecular Pathology Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. Japan Molecular Pathology Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. Japan Molecular Pathology Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. South Korea Molecular Pathology Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. South Korea Molecular Pathology Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. South Korea Molecular Pathology Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. India Molecular Pathology Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. India Molecular Pathology Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. India Molecular Pathology Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. Australia Molecular Pathology Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. Australia Molecular Pathology Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. Australia Molecular Pathology Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. Southeast Asia Molecular Pathology Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. Southeast Asia Molecular Pathology Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. Southeast Asia Molecular Pathology Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Brazil Molecular Pathology Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Brazil Molecular Pathology Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Brazil Molecular Pathology Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Argentina Molecular Pathology Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Argentina Molecular Pathology Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Argentina Molecular Pathology Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Chile Molecular Pathology Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Chile Molecular Pathology Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Chile Molecular Pathology Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Colombia Molecular Pathology Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Colombia Molecular Pathology Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Colombia Molecular Pathology Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Peru Molecular Pathology Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Peru Molecular Pathology Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Peru Molecular Pathology Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. Saudi Arabia Molecular Pathology Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. Saudi Arabia Molecular Pathology Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. Saudi Arabia Molecular Pathology Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Israel Molecular Pathology Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Israel Molecular Pathology Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Israel Molecular Pathology Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. UAE Molecular Pathology Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. UAE Molecular Pathology Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. UAE Molecular Pathology Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. Turkey Molecular Pathology Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. Turkey Molecular Pathology Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. Turkey Molecular Pathology Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. Iran Molecular Pathology Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 115. Iran Molecular Pathology Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 116. Iran Molecular Pathology Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 117. Egypt Molecular Pathology Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 118. Egypt Molecular Pathology Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 119. Egypt Molecular Pathology Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 120. Years Considered Figure 121. Research Process Figure 122. Key Executives Interviewed

Scope & coverage.

Types
  • Solid Tumor Molecular Pathology Services
  • Hematologic Malignancy Molecular Pathology Services
  • Hereditary Disease Molecular Pathology Services
  • Infectious Disease Molecular Testing Services
  • Rare Disease Molecular Pathology Services
  • Others
Applications
  • Hospitals and Medical Centers
  • Independent Clinical Laboratories
  • Academic and Research Institutes
  • Biopharmaceutical Companies
  • Others
Companies covered
  • Quest Diagnostics
  • Labcorp
  • Sonic Healthcare
  • NeoGenomics
  • Foundation Medicine
  • Caris Life Sciences
  • Tempus
  • Guardant Health
  • Exact Sciences
  • Eurofins
  • Unilabs

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Molecular Pathology Services Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Molecular Pathology Services Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Molecular Pathology Services Market Dynamics
  1. 2.1 Molecular Pathology Services Industry Trends
  2. 2.2 Molecular Pathology Services Industry Drivers
  3. 2.3 Molecular Pathology Services Industry Opportunities and Challenges
  4. 2.4 Molecular Pathology Services Industry Restraints
3 Molecular Pathology Services Market by Company
  1. 3.1 Global Molecular Pathology Services Company Revenue Ranking in 2025
  2. 3.2 Global Molecular Pathology Services Revenue by Company (2021-2026)
  3. 3.3 Global Molecular Pathology Services Company Ranking (2024-2026)
  4. 3.4 Global Molecular Pathology Services Company Manufacturing Base and Headquarters
  5. 3.5 Global Molecular Pathology Services Company Product Type and Application
  6. 3.6 Global Molecular Pathology Services Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Molecular Pathology Services Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Molecular Pathology Services Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Molecular Pathology Services Market by Type
  1. 4.1 Molecular Pathology Services Type Introduction
  2. 4.1.1 Solid Tumor Molecular Pathology Services
  3. 4.1.2 Hematologic Malignancy Molecular Pathology Services
  4. 4.1.3 Hereditary Disease Molecular Pathology Services
  5. 4.1.4 Infectious Disease Molecular Testing Services
  6. 4.1.5 Rare Disease Molecular Pathology Services
  7. 4.1.6 Others
  8. 4.2 Global Molecular Pathology Services Sales Value by Type
  9. 4.2.1 Global Molecular Pathology Services Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.2.2 Global Molecular Pathology Services Sales Value by Type (2021-2032)
  11. 4.2.3 Global Molecular Pathology Services Sales Value Share by Type (2021-2032)
5 Molecular Pathology Services Market by Application
  1. 5.1 Molecular Pathology Services Application Introduction
  2. 5.1.1 Hospitals and Medical Centers
  3. 5.1.2 Independent Clinical Laboratories
  4. 5.1.3 Academic and Research Institutes
  5. 5.1.4 Biopharmaceutical Companies
  6. 5.1.5 Others
  7. 5.2 Global Molecular Pathology Services Sales Value by Application
  8. 5.2.1 Global Molecular Pathology Services Sales Value by Application (2021 VS 2025 VS 2032)
  9. 5.2.2 Global Molecular Pathology Services Sales Value by Application (2021-2032)
  10. 5.2.3 Global Molecular Pathology Services Sales Value Share by Application (2021-2032)
6 Molecular Pathology Services Regional Value Analysis
  1. 6.1 Global Molecular Pathology Services Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Molecular Pathology Services Sales Value by Region (2021-2032)
  3. 6.2.1 Global Molecular Pathology Services Sales Value by Region: 2021-2026
  4. 6.2.2 Global Molecular Pathology Services Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Molecular Pathology Services Sales Value (2021-2032)
  7. 6.3.2 North America Molecular Pathology Services Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Molecular Pathology Services Sales Value (2021-2032)
  10. 6.4.2 Europe Molecular Pathology Services Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Molecular Pathology Services Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Molecular Pathology Services Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Molecular Pathology Services Sales Value (2021-2032)
  16. 6.6.2 South America Molecular Pathology Services Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Molecular Pathology Services Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Molecular Pathology Services Sales Value Share by Country, 2025 VS 2032
7 Molecular Pathology Services Country-level Value Analysis
  1. 7.1 Global Molecular Pathology Services Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Molecular Pathology Services Sales Value by Country (2021-2032)
  3. 7.2.1 Global Molecular Pathology Services Sales Value by Country (2021-2026)
  4. 7.2.2 Global Molecular Pathology Services Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Molecular Pathology Services Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Molecular Pathology Services Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Molecular Pathology Services Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Molecular Pathology Services Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Molecular Pathology Services Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Molecular Pathology Services Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Molecular Pathology Services Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Molecular Pathology Services Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Molecular Pathology Services Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Molecular Pathology Services Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Molecular Pathology Services Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Molecular Pathology Services Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Molecular Pathology Services Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Molecular Pathology Services Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Molecular Pathology Services Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Molecular Pathology Services Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Molecular Pathology Services Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Molecular Pathology Services Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Molecular Pathology Services Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Molecular Pathology Services Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Molecular Pathology Services Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Molecular Pathology Services Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Molecular Pathology Services Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Molecular Pathology Services Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Molecular Pathology Services Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Molecular Pathology Services Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Molecular Pathology Services Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Molecular Pathology Services Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Molecular Pathology Services Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Molecular Pathology Services Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Molecular Pathology Services Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Molecular Pathology Services Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Molecular Pathology Services Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Molecular Pathology Services Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Molecular Pathology Services Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Molecular Pathology Services Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Molecular Pathology Services Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Molecular Pathology Services Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Molecular Pathology Services Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Molecular Pathology Services Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Molecular Pathology Services Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Molecular Pathology Services Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Molecular Pathology Services Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Molecular Pathology Services Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Molecular Pathology Services Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Molecular Pathology Services Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Molecular Pathology Services Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Molecular Pathology Services Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Molecular Pathology Services Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Molecular Pathology Services Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Molecular Pathology Services Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Molecular Pathology Services Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Molecular Pathology Services Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Molecular Pathology Services Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Molecular Pathology Services Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Molecular Pathology Services Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Molecular Pathology Services Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Molecular Pathology Services Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Molecular Pathology Services Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Molecular Pathology Services Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Molecular Pathology Services Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Molecular Pathology Services Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Molecular Pathology Services Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Molecular Pathology Services Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Molecular Pathology Services Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Molecular Pathology Services Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Molecular Pathology Services Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Molecular Pathology Services Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Molecular Pathology Services Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Molecular Pathology Services Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Molecular Pathology Services Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Molecular Pathology Services Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Molecular Pathology Services Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Molecular Pathology Services Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Molecular Pathology Services Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Molecular Pathology Services Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Molecular Pathology Services Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Molecular Pathology Services Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Molecular Pathology Services Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Molecular Pathology Services Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Molecular Pathology Services Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Molecular Pathology Services Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Molecular Pathology Services Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Molecular Pathology Services Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Quest Diagnostics
  2. 8.1.1 Quest Diagnostics Company Information
  3. 8.1.2 Quest Diagnostics Business Overview
  4. 8.1.3 Quest Diagnostics Molecular Pathology Services Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Quest Diagnostics Molecular Pathology Services Product Portfolio
  6. 8.1.5 Quest Diagnostics Recent Developments
  7. 8.2 Labcorp
  8. 8.2.1 Labcorp Company Information
  9. 8.2.2 Labcorp Business Overview
  10. 8.2.3 Labcorp Molecular Pathology Services Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Labcorp Molecular Pathology Services Product Portfolio
  12. 8.2.5 Labcorp Recent Developments
  13. 8.3 Sonic Healthcare
  14. 8.3.1 Sonic Healthcare Company Information
  15. 8.3.2 Sonic Healthcare Business Overview
  16. 8.3.3 Sonic Healthcare Molecular Pathology Services Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Sonic Healthcare Molecular Pathology Services Product Portfolio
  18. 8.3.5 Sonic Healthcare Recent Developments
  19. 8.4 NeoGenomics
  20. 8.4.1 NeoGenomics Company Information
  21. 8.4.2 NeoGenomics Business Overview
  22. 8.4.3 NeoGenomics Molecular Pathology Services Revenue and Gross Margin (2021-2026)
  23. 8.4.4 NeoGenomics Molecular Pathology Services Product Portfolio
  24. 8.4.5 NeoGenomics Recent Developments
  25. 8.5 Foundation Medicine
  26. 8.5.1 Foundation Medicine Company Information
  27. 8.5.2 Foundation Medicine Business Overview
  28. 8.5.3 Foundation Medicine Molecular Pathology Services Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Foundation Medicine Molecular Pathology Services Product Portfolio
  30. 8.5.5 Foundation Medicine Recent Developments
  31. 8.6 Caris Life Sciences
  32. 8.6.1 Caris Life Sciences Company Information
  33. 8.6.2 Caris Life Sciences Business Overview
  34. 8.6.3 Caris Life Sciences Molecular Pathology Services Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Caris Life Sciences Molecular Pathology Services Product Portfolio
  36. 8.6.5 Caris Life Sciences Recent Developments
  37. 8.7 Tempus
  38. 8.7.1 Tempus Company Information
  39. 8.7.2 Tempus Business Overview
  40. 8.7.3 Tempus Molecular Pathology Services Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Tempus Molecular Pathology Services Product Portfolio
  42. 8.7.5 Tempus Recent Developments
  43. 8.8 Guardant Health
  44. 8.8.1 Guardant Health Company Information
  45. 8.8.2 Guardant Health Business Overview
  46. 8.8.3 Guardant Health Molecular Pathology Services Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Guardant Health Molecular Pathology Services Product Portfolio
  48. 8.8.5 Guardant Health Recent Developments
  49. 8.9 Exact Sciences
  50. 8.9.1 Exact Sciences Company Information
  51. 8.9.2 Exact Sciences Business Overview
  52. 8.9.3 Exact Sciences Molecular Pathology Services Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Exact Sciences Molecular Pathology Services Product Portfolio
  54. 8.9.5 Exact Sciences Recent Developments
  55. 8.10 Eurofins
  56. 8.10.1 Eurofins Company Information
  57. 8.10.2 Eurofins Business Overview
  58. 8.10.3 Eurofins Molecular Pathology Services Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Eurofins Molecular Pathology Services Product Portfolio
  60. 8.10.5 Eurofins Recent Developments
  61. 8.11 Unilabs
  62. 8.11.1 Unilabs Company Information
  63. 8.11.2 Unilabs Business Overview
  64. 8.11.3 Unilabs Molecular Pathology Services Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Unilabs Molecular Pathology Services Product Portfolio
  66. 8.11.5 Unilabs Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst